Zimmer Biomet Holdings, Inc. (ZBH)
| Market Cap | 30.43B |
| Revenue (ttm) | 7.89B |
| Net Income (ttm) | 916.20M |
| Shares Out | 208.60M |
| EPS (ttm) | 4.39 |
| PE Ratio | 34.47 |
| Forward PE | 17.24 |
| Dividend | $0.96 (0.63%) |
| Ex-Dividend Date | Sep 29, 2021 |
| Volume | 718,099 |
| Open | 150.39 |
| Previous Close | 150.40 |
| Day's Range | 149.17 - 151.73 |
| 52-Week Range | 129.45 - 180.10 |
| Beta | 1.32 |
| Analysts | Buy |
| Price Target | 188.62 (+24.6%) |
| Est. Earnings Date | Nov 5, 2021 |
About ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as pr...
Financial Performance
Financial StatementsAnalyst Forecast
According to 30 analysts, the average rating for Zimmer Biomet stock is "Buy." The 12-month stock price forecast is 188.62, which is an increase of 24.63% from the latest price.
News
Strength Seen in Zimmer (ZBH): Can Its 4.7% Jump Turn into More Strength?
Zimmer (ZBH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zimmer Biomet Announces Key Additions to "NewCo" Leadership Team; Transaction to Form New Independent, Publicly Trade...
WARSAW, Ind., Sept. 14, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key appointments to the "NewCo" leadership team, includ...
Zimmer Biomet (ZBH) Hurt by EMEA's Slow Recovery Amid Pandemic
Zimmer Biomet's (ZBH) leveraged capital structure is an added concern.
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2021
WARSAW, Ind. , Sept. 3, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of...
Zimmer (ZBH) Up 1.8% Since Last Earnings Report: Can It Continue?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Zimmer Biomet's (ZBH) Data Favors mymobility with Apple Watch
Zimmer Biomet (ZBH) presented four data presentations backing the mymobility with Apple Watch platform at the AAOS 2021 Annual Meeting.
Zimmer Biomet Announces New Data Supporting Clinical Benefits of mymobility® with Apple Watch® at AAOS 2021
WARSAW, Ind., Aug. 31, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced four data presentations on the clinical value of mymobil...
Zimmer Biomet to Present at Baird's 2021 Virtual Global Healthcare Conference
WARSAW, Ind., Aug. 31, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chairman, President and CEO Bryan Hanson and Execut...
Zimmer Biomet and Canary Medical Announce FDA De Novo Classification Grant and Authorization to Market the World's Fi...
WARSAW, Ind. and VANCOUVER, BC, Aug. 30, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Canary Medical, a medical data company, today anno...
Zimmer Biomet (ZBH) Receives FDA Nod for ROSA Hip System
The recent FDA go-ahead for Zimmer Biomet's (ZBH) ROSA Hip System will aid surgeons perform robotically-assisted direct anterior total hip replacement surgery.
FDA Approves Zimmer Biomet's Rosa Hip Personalized Robotic System
Zimmer Biomet Holdings Inc (NYSE: ZBH) has received FDA 510(k) clearance for its Rosa Hip system for robotically-assisted surgery. The system is designed for direct anterior total hip replacement.
Zimmer Biomet Receives FDA Clearance for ROSA® Hip System for Robotically-Assisted Direct Anterior Total Hip Arthropl...
WARSAW, Ind., Aug. 18, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
Zimmer Biomet to Unveil New Clinical Data and Portfolio of Innovative Technologies at AAOS 2021 Annual Meeting
WARSAW, Ind., Aug. 17, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced six data presentations at the American Academy of Orthop...
Zimmer Biomet (ZBH) Recovery Rate Slows Down Amid Pandemic
Zimmer Biomet (ZBH) sees slower recovery amid the emergence of a new strain of coronavirus in a number of markets, including Japan.
Will Zimmer Biomet Holdings Stock Rebound After A 9% Fall In A Week
The stock price of Zimmer Biomet Holdings, a medical devices company, reached its all-time high of $178 in April this year, but it has since seen lower levels. A recent sell-off in the stock has led to ...
Zimmer Biomet Stock Falls After Lowering Bottom End Of FY21 Outlook; Q2 Earnings Beat
Zimmer Biomet Holdings Inc (NYSE: ZBH) posted Q2 adjusted EPS of $1.90, ahead of the consensus of $1.87 and higher than $0.05 posted a year ago. It reported a profit of $142.5 million, upping its bottom...
Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Expand
Zimmer Biomet (ZBH) sales improve across all its operating segments and geographies on recovery from the pandemic in the months of the second quarter.
Zimmer Biomet (ZBH) Q2 Earnings and Revenues Surpass Estimates
Zimmer (ZBH) delivered earnings and revenue surprises of 3.26% and 2.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Zimmer Biomet Q2 Earnings
Shares of Zimmer Biomet Holdings (NYSE:ZBH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 3700.00% over the past year to $1.90, which beat the esti...
Is a Surprise Coming for Zimmer Biomet (ZBH) This Earnings Season?
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for Zimmer Biomet (ZBH) in Q2 Earnings?
Zimmer Biomet's (ZBH) S.E.T. is expected to have performed better than expected on the back of the company's focus on sports and extremities, especially upper extremities, trauma and CMFT.
Zimmer Biomet (ZBH) Earnings Expected to Grow: Should You Buy?
Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Which stocks you should own if the economy slows due to delta
Cliff Hodge, Chief Investment Officer at Cornerstone Wealth and Mark Avallone, President of Potomac Wealth Advisors, join Kelly Evans on The Exchange to discuss their top stock picks to hold onto if the...
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.